Syncop
Demo — not signed in Sign in 22
Demo data. This console is backed by an in-memory sample dataset. Signing here is a UI demonstration only — it is not a validated 21 CFR Part 11 electronic signature, and the audit chain it appends to is rebuilt from seed data on every restart.

Protocols

SYN-441 Phase III Oncology

Version 1

A Phase III, randomized, double-blind, placebo-controlled study of SYN-441 in adults with advanced solid tumors.

Schedule of Activities

This version has no Schedule of Activities to show: Study design sd-1 has no main timeline

Versions

Every version, newest first. A version is never changed; each names the one it revised.
Version Revised Recorded Source Amendments introduced Document hash LeanDelegate
v1 — 29 Sep 2026 15:06 UTC API — 00595148b44aa186… Not assimilated

Structure

The study definition as USDM holds it, entity by entity. Open a part to see what it holds.